Eric Gisiger

Functions as a College/University

Man Investments is an active, research-driven manager which utilizes top-down and bottom-up investment approaches to identify the best performing managers in each style and the best mix of styles and managers in each portfolio. The firm performs due diligence on each investment opportunity and manager, conducting site visits, risk management and legal checks. The investment strategy is a macro framework within which senior investment professionals determine and manage the top-down aspects of the investment processes, including current and anticipated industry-wide trends and developments. The investment strategy for each asset class is conceptualized in terms of strategic and tactical allocation processes. Strategic asset allocation is computed using a proprietary program that optimizes the risk-return profile of the portfolio. For fixed-income investments, Man Investments implements a combined top-down and bottom-up investment process, starting with a broadly diversified portfolio which matches the sector and country allocation of its benchmark, then weighting regions, sectors or countries based on qualitative and quantitative assumptions made in the firm's quarterly market review. Their AHL division runs several managed futures investment programs using systematic trading models and statistical analysis to identify pricing inefficiencies in hundreds of financial instruments traded on highly-regulated exchanges around the world. The managed futures trading approach is predominantly trend-following, seeking to profit from movements in the price of instruments whether the price is rising or falling.

Develops and manufactures antimicrobial silver and sustainable textile effects

Credit Suisse Entrepreneur Capital invests in companies located in Switzerland. The firm targets companies operating across a broad range of sectors and industries. It provides financing in form of equity, mezzanine and loans for buyout, early and later stage capital requirements with an investment size of CHF 0.25 - 8 million.

Specializes in the development and licensing of novel medical devices and pharmaceutical products